Stockscreener 앱 받기
19.75
8.52%
1.55
시간 외 거래:
19.75
Staar Surgical Co 주식(STAA)의 최신 뉴스
Eye lens maker STAAR Surgical sets March 3 call on 2025 results, China recovery - Stock Titan
FDA expands age indication for STAAR’s EVO ICL to patients aged 21–60 years - Optometry Times
STAAR Surgical Company (STAA) Stock Analysis: Navigating Growth Amidst a 27.10% Potential Upside - DirectorsTalk Interviews
FDA approves expanded age indication for STAAR's EVO/EVO+ Visian ICLs - Eyes On Eyecare
STAA Gains FDA Nod to Expand EVO ICL Age Indication to 60 Years - Yahoo Finance
FDA Approves Expanded Age Range for STAAR Surgical’s EVO ICL for Vision Correction - VisionMonday.com
Alcon launches TOTAL30 Multifocal for Astigmatism toric contact lens - Eyes On Eyecare
Midday Stock Roundup: Staar Surgical up on FDA approval - Orange County Business Journal
FDA expands age indication for Staar Surgical EVO ICL - MassDevice
Why Is Staar Surgical Stock Gaining Wednesday?Staar Surgical (NASDAQ:STAA) - Benzinga
Staar Surgical Gains Key FDA Approval to Broaden Patient Eligibility - AD HOC NEWS
FDA approved expanded age indication for EVO/EVO+ Visian implantable lenses - TipRanks
STAAR Surgical (STAA) Expands Lens Use with FDA Approval - GuruFocus
FDA expands U.S. age indication for EVO ICL - marketscreener.com
FDA clears STAAR eye lens for ages 21–60, opening option for 8M more - Stock Titan
New Alcon lens helps aging eyes stay in contacts all month - Stock Titan
Credit Industriel ET Commercial Invests $3.26 Million in STAAR Surgical Company $STAA - MarketBeat
3 Low-Volatility Stocks We Find Risky - Finviz
New York Life Investment Management LLC Takes Position in STAAR Surgical Company $STAA - MarketBeat
STAAR Surgical Company (STAA) Stock Analysis: Exploring a 37.81% Potential Upside for Investors - DirectorsTalk Interviews
Alpine Associates Management Inc. Acquires Shares of 913,087 STAAR Surgical Company $STAA - MarketBeat
VIEW Optometry launches to support independent practices - Eyes On Eyecare
STAAR Surgical Company (NASDAQ:STAA) Given Average Recommendation of "Reduce" by Analysts - MarketBeat
212,421 Shares in STAAR Surgical Company $STAA Acquired by Versor Investments LP - MarketBeat
Eli Lilly To Rally More Than 21%? Here Are 10 Top Analyst Forecasts For Monday - Benzinga
STAAR Surgical (NASDAQ:STAA) Given New $19.00 Price Target at Stifel Nicolaus - MarketBeat
Staar Surgical price target lowered to $19 from $28 at Stifel - TipRanks
Leadership watch: Staar Surgical names co-CEOs, ACET adds to Board - Eyes On Eyecare
STAAR Surgical stock price target lowered to $19 by Stifel on China concerns By Investing.com - Investing.com India
STAAR Surgical stock price target lowered to $19 by Stifel on China concerns - Investing.com Nigeria
Staar Surgical CoEnters agreement with Chief Legal Officer Nathaniel SisitskySEC filing - marketscreener.com
STAAR Surgical Company (STAA): A Bull Case Theory - Finviz
Staar Surgical initiated with a Neutral at Wedbush - TipRanks
STAAR Surgical sinks as it plans to terminate sale to Alcon (update) - MSN
Staar Surgical (STAA) to Report Q4 Results: Wall Street Expects Earnings Growth - Finviz
STAA Receives Neutral Rating as Wedbush Initiates Coverage | STA - GuruFocus
STAAR names interim co-CEOs amid search for permanent leader - MedTech Dive
STAAR Surgical (NASDAQ:STAA) Now Covered by Wedbush - MarketBeat
STAAR Surgical (STAA) Projected to Post Quarterly Earnings on Tuesday - MarketBeat
STAAR Surgical Names Warren Foust and Deborah Andrews Interim Co-CEOs - VisionMonday.com
Why STAAR Surgical (STAA) stock is trading lower today - MSN
Staar Surgical names interim co-CEOs in leadership shift following failed Alcon deal - massdevice.com
Why STAAR Surgical (STAA) Shares Are Down Today - Bitget
Why STAAR Surgical (STAA) Stock Is Trading Lower Today - Finviz
Staar Surgical Appoints Interim Co-CEOs - Orange County Business Journal
STAAR Surgical Appoints Warren Foust and Deborah Andrews Interim Co-CEOs - PharmiWeb.com
New weekly contact lens offers Canadians 16 hours of daily comfort - stocktitan.net
Staar Surgical appoints Warren Foust & Deborah Andrews interim co-CEOs - marketscreener.com
STAAR Surgical Company Announces Interim Co-CEO Appointments, Effective February 1, 2026 - marketscreener.com
Staar Surgical (STAA) Appoints Interim Co-CEOs as CEO Search Beg - GuruFocus
A month after Alcon deal fell through, Staar Surgical searches for next CEO and names interim leaders - Fierce Biotech
Staar Surgical Names Interim Co-CEOs Amid Leadership Transition - TipRanks
Staar Surgical appoints COO Warren Foust, CFO Deborah Andrews as interim co-CEOs - TipRanks
STAAR Surgical Company (STAA) Stock Analysis: Insights Into The 23.34% Potential Upside - DirectorsTalk Interviews
Alcon Targets Faster Growth In 2026 With New Cataract Surgery Systems - Benzinga
1.06%
0.12%
자본화:
|
볼륨(24시간):